Suchergebnisse - "Xu, Binghe"

PubPharm (519)

1

Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer : A prospective study

enthalten in: Thoracic cancer | 2024

von Wu, Y. | Mo, H. | Xu, H. | +4

2

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

enthalten in: The oncologist | 2024

von Piha-Paul, S. | Xu, B. | Dumbrava, E. | +22

3

TROPION-Breast01 : Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer

enthalten in: Future oncology (London, England) | 2024

von Bardia, A. | Jhaveri, K. | Kalinsky, K. | +21

4

Ribociclib plus Endocrine Therapy in Early Breast Cancer

enthalten in: The New England journal of medicine | 2024

von Slamon, D. | Lipatov, O. | Nowecki, Z. | +28

5

Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patients

enthalten in: Journal of cancer research and therapeutics | 2024

von Lin, S. | Wang, S. | Xu, B.

6

Prognostic value and relapse pattern of HER2-low in hormone receptor-positive breast cancer

enthalten in: Thoracic cancer | 2024

von Wei, T. | Kang, Y. | Wang, X. | +3

7

A phase I study of Hemay022, an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer

enthalten in: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu | 2024

von Zhang, P. | Wang, L. | Zhen, Y. | +4

8

New insights into HER2-low breast cancer brain metastasis : A retrospective analysis

enthalten in: Breast (Edinburgh, Scotland) | 2024

von Xu, H. | Wang, Y. | Li, L. | +5

9

An immunogenic cell death-related signature for prediction of prognosis and response to immunotherapy in breast cancer

enthalten in: Chinese medical journal | 2024

von Li, C. | Guo, F. | Zhai, J. | +3

10

The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer : a multicenter phase II trial

enthalten in: Nature communications | 2024

von Li, Q. | Liu, J. | Zhang, Q. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[52]